Abstract
Micromolar concentrations of glutamate, acting at non-NMDA, kainate-preferring receptors, increased the survival of cultured mouse hippocampal neurons maintained in serum-free, chemically-defined medium. Glutamate in excess of 20 μM was excitotoxic. Thus, the survival versus glutamate dose response relation was bell-shaped with an optimal glutamate concentration near 1 μM. Hippocampal neurons from mice with the genetic defect, trisomy 16 (Ts16), died 2–3 times faster than normal (euploid) neurons. Moreover, glutamate, at all concentrations tested, failed to increase survival of Ts16 neurons. Ts16 is a naturally-occurring mouse genetic abnormality, the human analog of which (Down syndrome) leads to altered brain development and Alzheimer’s disease. These results demonstrate that the Ts16 genotype confers a defect in the glutamate-mediated survival response of hippocampal neurons and that this defect can account for their accelerated death.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M.C. Raff, B.A. Barres, J.F. Burne, H.S. Coles, Y. Ishizaki, and M.D. Jacobson, Programmed cell death and the control of cell survival: Lessons from the nervous system. Science 269:695–700 (1993).
H. Potter, Review and hypothesis: Alzheimer disease and Down syndrome — chromosome 21 nondisjunction may underlie both disorders. Am. J. Hum. Genet. 48:1192–1200 (1991).
D.M.A. Mann, Down’s syndrome and Alzheimer’s disease: Towards an understanding of the pathogenesis. in “Neurodegeneration”, A.J. Hunter and M. Clark, eds. Academic Press, San Diego, CA (1992).
J.T. Coyle, M.L. Oster-Granite, R.H. Reeves, and J.D. Gearhart, Down syndrome, Alzheimer’s disease and the trisomy 16 mouse. Trends Neurosci. 11:390–394 (1988).
P. Gregor, R.H. Reeves, E.W. Jabs, X. Yang, W. Dackowski, J.M. Rochelle, R.H. Brown, Jr., J.L. Haines, B.F. O’Hara, G.R. Uhl, and M.F. Seldin, Chromosomal localization of glutamate receptor genes: relationship to familial amyotrophic lateral sclerosis and other neurological disorders of mice and humans. Proc. Natl Acad. Sci USA 90:3053–3057 (1993).
H.S. Singer, M. Tiemeyer, J.C. Hedreen, J. Gearhart, and J.T. Coyle, Morphologic and neurochemical studies of embryonic brain development in murine trisomy 16. Dev. Brain Res. 15:155–166 (1984).
J.D. Gearhart, M.L. Oster-Granite, R.H. Reeves, and J.T. Coyle, Developmental consequences of autosomal aneuploidy in mammals. Dev. Genet. 8:249–265 (1987).
J. Kiss, M. Schlumpf, and R. Balazs, Selective retardation of the development of the basal forebrain cholinergic and pontine catecholaminergic nuclei in the brain of trisomy 16 mouse, an animal model of Down’s syndrome. Dev. Brain Res. 50:251–264 (1989).
J.E. Sweeney, C.F. Hohmann, M.L. Oster-Granite, and J.T. Coyle, Neurogenesis of the basal forebrain in euploid and trisomy 16 mice: an animal model for developmental disorders in Down syndrome. Neuroscience 31:413–425 (1989).
M.L. Oster-Granite, The trisomy 16 mouse as an animal model relevant to studies of growth retardation in Down’s syndrome, in “Growth Hormone Treatment in Down’s Syndrome”, S. Castells and K.E. Wisniewski, eds. John Wiley and Sons Ltd, New York (1993).
P. Corsi and J.T. Coyle, Nerve growth factor corrects developmental impairments of basal forebrain cholinergic neurons in the trisomy 16 mouse. Proc. Natl Acad. Sci USA 88:1793–1797 (1991).
D.M. Holtzman, Y. Li, S.J. DeArmond, M.P. McKinley, F.H. Gage, C.J. Epstein, and W.C. Mobley, Mouse model of neurodegeneration: atrophy of basal forebrain cholinergic neurons in trisomy 16 transplants. Proc. Natl Acad. Sci USA 89:1383–1387 (1992).
G.J. Brewer, J.R. Torricelli, E.K. Evege, and P.J. Price, Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci Res. 35:567–576 (1993).
K. Unsicker, H. Reichert-Preibsch, R. Schmidt, B. Pettmann, G. Labourdette, and M. Sensenbrenner, Astroglial and fibroblast growth factors have neurotrophic functions for cultured peripheral and central nervous system neurons. Proc. Natl Acad. Sci USA 84:5459–5463 (1987).
D.W. Choi, Excitotoxic cell death. J. Neurobiol. 23:1261–1276 (1992).
R. Balazs, O.S. Jorgensen, and N. Hack, N-Methyl-D-aspartate promotes the survival of cerebellar granule cells in culture. Neuroscience 27:437–451 (1988).
R.D. Burgoyne, M.E. Graham, and M. Cambray-Deakin, Neurotrophic effects of NMDA receptor activation on developing cerebellar granule cells. J. Neurocyt. 22:689–695 (1993).
G.-M. Yan, B. Ni, M. Weller, K.A. Wood, and S.M. Paul, Depolarization or glutamate receptor activation blocks apoptotic cell death of cultured cerebellar granule neurons. Brain Res. 656:43–51 (1994).
E. Gould, H.A. Cameron, and B.S. McEwen, Blockade of NMDA receptors increases cell death and birth in the developing rat dentate gyrus. J. Comp. Ncurol. 340:551–565 (1994).
H.T.J. Mount, C.F. Dreyfus, and I.B. Black, Purkinje cell survival is differentially regulated by metabotropic and ionotropic excitatory amino acid receptors. J. Neurosci. 13:3173–3179 (1993).
A. Copani, V.M.G. Bruno, V. Barresi, G. Battaglia, D.F. Condorelli, and F. Nicoletti, Activation of metabotropic glutamate receptors prevents neuronal apoptosis in culture. J. Neurosci. 64:101–108 (1995).
A. Lehman, H. Isacsson, and A. Hamberger, Effects of in vivo administration of kainic acid on the extracellular amino acid pool in the rabbit hippocampus. J. Neurochem. 40:1314–1320 (1983).
K. Sugiyama, A. Brunori, and M.L. Mayer, Glial uptake of excitatory amino acids influences neuronal survival in cultures of mouse hippocampus. Neuroscience 32:779–791 (1989).
M.P. Mattson and B. Rychlik, Glia protect hippocampal neurons against excitatory amino acid-induced degeneration: involvement of fibroblast growth factor. Int. J. Devl. Neurosci 8:399–415 (1990).
J.D. Rothstein, L. Jin, M. Dykes-Hoberg, and R.W. Kuncl, Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl Acad. Sci USA 90:6591–6595 (1993).
V. Parpura, T.A. Basarsky, F. Liu, K. Jeftinija, S. Jeftinija, and P.G. Haydon, Glutamate-mediated astrocyte-neuron signalling. Nature 369:744–747 (1994).
G. Pepeu, L. Ballerini, and A.M. Pugliese, Neurotrophic factors in the aging brain: a review. Arch. Gerontol Geriatr. Suppl. 2:151–158 (1991).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bambrick, L.L., Yarowsky, P.J., Krueger, B.K. (1996). Glutamate-Promoted Survival in Hippocampal Neurons: A Defect in Mouse Trisomy 16. In: Fiskum, G. (eds) Neurodegenerative Diseases. GWUMC Department of Biochemistry and Molecular Biology Annual Spring Symposia. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0209-2_19
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0209-2_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0211-5
Online ISBN: 978-1-4899-0209-2
eBook Packages: Springer Book Archive